Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in Exp Hematol Retrieve available abstracts of 54 articles: HTML format Text format

Single Articles

February 2010
1. DECOT V , Voillard L, Latger-Cannard V, Aissi-Rothe L, et al
   Natural Killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of 3 cytokines IL-2, IL-15 or IL-7 and impact on NKG2D, KIR2DL1 and KIR2DL2 expression.
   Exp Hematol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. ALZANI R , Pedrini O, Albanese C, Ceruti R, et al
   Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high burden leukemia models.
   Exp Hematol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
3. HEUSER M , Park G, Moon Y, Berg T, et al
   Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemia.
   Exp Hematol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
4. CITORES MJ , Castejon R, Villarreal M, Rosado S, et al
   CD154 expression triggered by purine analogues in vitro. Correlation with treatment response and autoimmune events in chronic lymphocytic leukemia.
   Exp Hematol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
5. SHIOZAWA Y , Pedersen EA, Taichman RS
   GAS6/Mer axis regulates the homing and survival of the E2A/PBX1 positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche.
   Exp Hematol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
6. CHEUNG AM , Fung TK, Fan AK, Wan TS, et al
   Successful engraftment by leukemia initiating cells in adult acute lymphoblastic leukemia after direct intra-hepatic injection into unconditioned newborn NOD/SCID mice.
   Exp Hematol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. RAN D , Schubert M, Pietsch L, Taubert I, et al
   Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcome.
   Exp Hematol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. BALSAMO M , Zambello R, Teramo A, Pedrazzi M, et al
   Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30.
   Exp Hematol. 2009;37:1167-75.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
9. SHIRAI K , Sera Y, Bulkeley W, Mehrotra M, et al
   Hematopoietic Stem Cell Origin of Human Fibroblasts: Cell Culture Studies of Female Recipients of Gender Mismatch Stem Cell Transplantation and Patients with Chronic Myelogenous Leukemia.
   Exp Hematol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   August 2009
10. LI J , Hu XF, Loveland BE, Xing PX, et al
    Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. RAZUMOVSKAYA E , Masson K, Khan R, Bengtsson S, et al
    Oncogenic Flt3 receptors display different specificity and kinetics of autophosphorylation.
    Exp Hematol. 2009;37:979-89.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
12. THAKAR MS , Zhang XB, Beard BC, Sale GE, et al
    Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: Implications for a new canine leukemia model.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CELLAI C , Laurenzana A, Bianchi E, Sdelci S, et al
    Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: The crucial role of PTEN.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
14. YAMAGUCHI H , Hanawa H, Uchida N, Inamai M, et al
    Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Exp Hematol. 2009;37:701-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BARBARROJA N , Torres LA, Luque MJ, Carretero RM, et al
    Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
    Exp Hematol. 2009;37:679-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. DOUBEK M , Palasek I, Pospisil Z, Borsky M, et al
    Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Exp Hematol. 2009;37:659-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SHIPLEY JL , Butera JN
    Acute myelogenous leukemia.
    Exp Hematol. 2009;37:649-58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. HAAG P , Viktorsson K, Lindberg ML, Kanter L, et al
    Deficient activation of Bak and Bax confers resistance to gemtuzumab ozogamicin-induced apoptotic cell death in AML.
    Exp Hematol. 2009;37:755-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
19. LU S , Yang J, Chen Z, Gong S, et al
    Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. ALBITAR M , Potts SJ, Giles FJ, O'Brien S, et al
    Proteomics-based prediction of clinical response in acute myeloid leukemia.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. GERY S , Gueller S, Nowak V, Sohn J, et al
    Expression of the adaptor protein Lnk in leukemia cells.
    Exp Hematol. 2009;37:585-592.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
22. KONDOH T , Kobayashi D, Tsuji N, Kuribayashi K, et al
    Overexpression of Serine Threonine Tyrosine Kinase 1/Novel Oncogene with Kinase Domain mRNA in Patients with Acute Leukemia.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. HATZIIEREMIA S , Jordanides NE, Holyoake TL, Mountford JC, et al
    Inhibition of MDR1 does not sensitize primitive chronic myeloid leukemia CD34(+) cells to imatinib.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. MURANYI AL , Dedhar S, Hogge DE
    Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
    Exp Hematol. 2009;37:450-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. ABE K , Shimizu R, Pan X, Hamada H, et al
    Stem cells of GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment.
    Exp Hematol. 2009;37:435-445.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. TIBULLO D , Giallongo C, La Cava P, Berretta S, et al
    Effects of imatinib mesylate in osteoblastogenesis.
    Exp Hematol. 2009;37:461-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
27. CRAWFORD LJ , Windrum P, Magill L, Melo JV, et al
    Proteasome proteolytic profile is linked to Bcr-Abl expression.
    Exp Hematol. 2009;37:357-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. HAMILTON A , Alhashimi F, Myssina S, Jorgensen HG, et al
    Optimization of methods for the detection of BCR-ABL activity in Philadelphia-positive cells.
    Exp Hematol. 2009;37:395-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
29. SCHAAR DG , Medina DJ, Moore DF, Strair RK, et al
    miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
    Exp Hematol. 2009;37:245-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. HIRABAYASHI Y , Tsuboi I, Kitada K, Igarashi K, et al
    Comparison of murine gene expression profiles between spontaneous and radiation-induced myelogenous leukemias: stochastic and probabilistic expression variances in the former vs radiation-specific expression commonalities in the latter.
    Exp Hematol. 2009;37:195-205.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
31. NIJMEIJER BA , Szuhai K, Goselink HM, van Schie ML, et al
    Long-term culture of primary human lymphoblastic leukemia cells in the absence of serum or hematopoietic growth factors.
    Exp Hematol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. BACHER U , Badbaran A, Fehse B, Zabelina T, et al
    Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.
    Exp Hematol. 2009;37:135-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. DOBBIN E , Graham C, Corrigan PM, Thomas KG, et al
    Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
    Exp Hematol. 2009;37:111-121.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. USHER SG , Radford AD, Villiers EJ, Blackwood L, et al
    RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
    Exp Hematol. 2009;37:65-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
35. NYGREN MK , Dosen-Dahl G, Stubberud H, Walchli S, et al
    beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. INOUE Y , Izawa K, Kiryu S, Kobayashi S, et al
    Bioluminescent evaluation of the therapeutic effects of total body irradiation in a murine hematological malignancy model.
    Exp Hematol. 2008;36:1634-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
37. WU J , Huang L, Huang M, Liu W, et al
    Dominant contribution of malignant endothelial cells to endotheliopoiesis in chronic myeloid leukemia.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. PIGNEUX A , Mahon FX, Uhalde M, Jeanneteau M, et al
    Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. BILLARD C , Menasria F, Quiney C, Faussat AM, et al
    4-Arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SEAL S , Hockenbery DM, Spaulding EY, Kiem HP, et al
    Differential responses of FLIP(Long) and FLIP(Short)-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. LIN TY , Bear M, Du Z, Foley KP, et al
    The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.
    Exp Hematol. 2008;36:1266-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. YANG Z , Li Y, Yin F, Chan RJ, et al
    Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival.
    Exp Hematol. 2008;36:1285-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
43. CARUSO DA , Fraser S, Hardy K, Amor G, et al
    Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
44. QIU H , Xu Y, Zhang J, Pan J, et al
    Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. SHOJAEI F , Menendez P
    Molecular profiling of candidate human hematopoietic stem cells derived from human embryonic stem cells.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SELLNER L , Stiefelhagen M, Kleinschmidt JA, Laufs S, et al
    Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
    Exp Hematol. 2008;36:957-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. AYUK F , Diyachenko G, Zabelina T, Panse J, et al
    Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Exp Hematol. 2008;36:1047-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
48. FATRAI S , Schepers H, Tadema H, Vellenga E, et al
    Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
    Exp Hematol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CASTILLO J , Winer E, Quesenberry P
    Newer monoclonal antibodies for hematological malignancies.
    Exp Hematol. 2008;36:755-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. ARGIROPOULOS B , Palmqvist L, Yung E, Kuchenbauer F, et al
    Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.
    Exp Hematol. 2008;36:845-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
51. LIN JM , Li B, Rimmer E, VanRoey M, et al
    Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.
    Exp Hematol. 2008;36:319-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. WLODARSKI MW , Nearman Z, Jiang Y, Lichtin A, et al
    Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia.
    Exp Hematol. 2008;36:293-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. SUZUKI M , Takata O, Sakaguchi S, Fujimura J, et al
    Retherapy using L-asparaginase with octreotide in a patient recovering from L-asparaginase-induced pancreatitis.
    Exp Hematol. 2008;36:253-4.
    PubMed     Text format     Related articles   
    
    
    
54. MUNUGALAVADLA V , Sims EC, Chan RJ, Lenz SD, et al
    Requirement for p85alpha regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KIT.
    Exp Hematol. 2008;36:301-8.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: